In this study, the levels of Rab3D in the normal tissues or benign tumors are low, whereas the high levels of Rab3D are closely correlated with tumor TNM staging not grade, showing that Rab3D is a potential selective target for cancer progression. The gene discussed is RAB3D; the disease is neoplasm.